Jackson Lab, Wuhan Frasergen Bioinformatics to Launch Tumor Research Facility in China | GenomeWeb

NEW YORK (GenomeWeb) – The Jackson Laboratory and Wuhan Frasergen Bioinformatics will create a cancer genomics research facility in China with the aim of developing new personalized treatments.

Under a memorandum of understanding, the companies plan to launch a facility in Wuhan, Hubei Province, which hosts a center for the Chinese Academy of Sciences, Jackson Lab said on Saturday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.